Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
주식 순위 #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
주가
$0.07600875
마지막 동기화: 2024-11-20
시가총액
$2.06M
변동 (1일)
-0.51%
변동 (1년)
0.00%
국가
FR
거래 Quantum Genomics S.A. (ALQGC)

카테고리

Quantum Genomics S.A. (ALQGC)의 P/B 비율
August 2026 기준 P/B 비율 TTM: -2.05
Quantum Genomics S.A.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 -2.05입니다. 2023년 말 기준 P/B 비율은 8.46였습니다.
Quantum Genomics S.A.의 P/B 비율 기록 (2009 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2026 (TTM) -2.05 -0.18%
2024 -2.05 -124.18%
2023 8.46 649.27%
2022 1.13 -90.55%
2021 11.95 194.68%
2020 4.06 -37.21%
2019 6.46 -8.65%
2018 7.07 87.24%
2017 3.78 -35.35%
2016 5.84 -20.06%
2015 7.31 -103.58%
2014 -204.14 1,261.27%
2013 -15.00 -41.14%
2012 -25.48 74.82%
2011 -14.57 70.19%
2010 -8.56 -101.36%
2009 630.17 0.00%
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
6.3419 -409.91%
US
6.2413 -404.99%
NL
- -
CH
- -
KR
3.4612 -269.14%
BE